Norbrook

Loxicom Oral Suspension for Dogs – Dual Pack

Name: Loxicom Oral Suspension for Dogs - Dual Pack
Availability: InStock

£28.75

Loxicom Oral Suspension for Dogs – Dual Pack is used to treat pain from acute and chronic musculoskeletal disorders e.g osteoarthritis.

Legal Category : POM-V

This product requires a prescription to be ordered.

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

View POM Delivery & Returns

Secure Checkout with

Loxicom oral suspension for dogs - dual pack is an oral suspension that contains the medication meloxicam. It is indicated for the alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dog.

Pale yellow oral suspension.

Directions

Oral use.

To be administered with food or directly into the mouth.

Shake well before use.

For longer-term treatment, once clinical response has been observed (after 4 days), the dose can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.

Particular care should be taken with regard to the accuracy of dosing.

The suspension can be given using either of the two measuring syringes provided in the package.

The syringes fit onto the bottle and have a kg-bodyweight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg bodyweight).

A clinical response is normally seen within 3-4 days.

Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

Directions

Oral use. To be administered with food or directly into the mouth.

Shake well before use.

Dosage: Post-operative pain and inflammation following surgical procedures: After initial treatment with Loxicom 5 mg/ml Solution for Injection for Dogs and Cats continue treatment 24 hours later with Loxicom 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight. The oral follow-up dose should be administered once daily (at 24-hour intervals) for up to four days.

Acute musculo-skeletal disorders: Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a dose of 0.05 mg meloxicam/kg body-weight for as long as acute pain and inflammation persist. Chronic musculo-skeletal disorders: Initial treatment is a single dose of 0.1 mg meloxicam/kg bodyweight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg bodyweight. A clinical response is normally seen within 7 days. Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.

Dosing Procedure: The syringe fits onto the bottle and has a kg-body weight scale that corresponds to the maintenance dose. Thus for initiation of the treatment of chronic musculo-skeletal disorders on the first day, twice the maintenance volume will be required. For initiation of the treatment of acute musculo-skeletal disorders on the first day, 4 times the maintenance volume will be required. Particular care should be taken with regard to the accuracy of dosing. The recommended dose should not be exceeded. The suspension should be given using the Loxicom measuring syringe provided in the package. Avoid introduction of contamination during use.

Product Description

Loxicom oral suspension for dogs – dual pack is an oral suspension that contains the medication meloxicam. It is indicated for the alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dog.

Pale yellow oral suspension.

Directions

Oral use.
To be administered with food or directly into the mouth.
Shake well before use.
For longer-term treatment, once clinical response has been observed (after 4 days), the dose can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
Particular care should be taken with regard to the accuracy of dosing.
The suspension can be given using either of the two measuring syringes provided in the package.
The syringes fit onto the bottle and have a kg-bodyweight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg bodyweight).
A clinical response is normally seen within 3-4 days.
Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

Directions

Oral use. To be administered with food or directly into the mouth.
Shake well before use.
Dosage: Post-operative pain and inflammation following surgical procedures: After initial treatment with Loxicom 5 mg/ml Solution for Injection for Dogs and Cats continue treatment 24 hours later with Loxicom 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight. The oral follow-up dose should be administered once daily (at 24-hour intervals) for up to four days.
Acute musculo-skeletal disorders: Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a dose of 0.05 mg meloxicam/kg body-weight for as long as acute pain and inflammation persist. Chronic musculo-skeletal disorders: Initial treatment is a single dose of 0.1 mg meloxicam/kg bodyweight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg bodyweight. A clinical response is normally seen within 7 days. Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.
Dosing Procedure: The syringe fits onto the bottle and has a kg-body weight scale that corresponds to the maintenance dose. Thus for initiation of the treatment of chronic musculo-skeletal disorders on the first day, twice the maintenance volume will be required. For initiation of the treatment of acute musculo-skeletal disorders on the first day, 4 times the maintenance volume will be required. Particular care should be taken with regard to the accuracy of dosing. The recommended dose should not be exceeded. The suspension should be given using the Loxicom measuring syringe provided in the package. Avoid introduction of contamination during use.